PT - JOURNAL ARTICLE AU - Costa, Amanda Almeida AU - Cota, Luís Otávio Miranda AU - Esteves Lima, Rafael Paschoal AU - Oliveira, Alcione Maria Soares Dutra AU - Cortelli, Sheila Cavalca AU - Cortelli, José Roberto AU - Cyrino, Renata Magalhães AU - Mendes, Victor Silva AU - Silva, Tarcília Aparecida AU - Costa, Fernando Oliveira TI - The association between periodontitis and the impact of oral health on the quality of life of individuals with psoriasis and psoriatic arthritis AID - 10.1101/2024.03.13.24304243 DP - 2024 Jan 01 TA - medRxiv PG - 2024.03.13.24304243 4099 - http://medrxiv.org/content/early/2024/03/15/2024.03.13.24304243.short 4100 - http://medrxiv.org/content/early/2024/03/15/2024.03.13.24304243.full AB - Objective To evaluate the association between psoriasis (PSO), psoriatic arthritis (PsA) and periodontitis (PE), and the Oral Health-Related Quality of Life (OHRQoL) impacts on individuals with psoriatic disease’s daily activities compared to the non-psoriatic ones.Materials & Methods 296 individuals with psoriatic disease (PSO n= 210, APS n= 86) (cases) and 359 without these diseases (controls) were included. Complete periodontal examinations and collection of variables of interest were performed. The Brazilian version of the Oral Impacts on Daily Performance (OIDP) instrument was applied.Results The prevalence of PE was higher in PsA (57.0%; OR=2.67 95%CI 1.65–4.32; p<0.001) than in PSO (34.3%; OR=1.05 95% CI 0.73–1.51; p<0.001) compared to controls (33.1%). Both PsA and PSO groups showed more sites and teeth with 4-6mm probing depth (PD) and had higher OIDP scores than controls (p<0.001), thus indicating worse self-reported quality of life. PE, PSO+PE and consumption of alcohol/anxiolytics significantly influenced OHRQoL (p<0.05). The influence of periodontal parameters on OHRQoL was observed for the presence of PE; PD >6 mm; clinical attachment level >6 mm; higher plaque index, % sites and teeth with bleeding on probing (p<0.05).Conclusion Negative impacts of PE on the OHRQoL were demonstrated. The ones having PSO and especially PsA and PE presented significantly worse indicators.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Research Ethics Committee from the Universidade Federal de Minas Gerais – Brazil (#CAAE 20156019.0.0000.5149).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data underlying the results presented in the study are available in the University's Postgraduate Department Universidade Federal de Minas Gerais. Contact information: posgrad{at}odonto.ufmg.br https://www.odonto.ufmg.br/posgrad/ https://www.odonto.ufmg.br/posgrad/